Chlamydia pneumoniae induces the expression of inhibitor of apoptosis 2 (c-IAP2) in a human monocytic cell line by an NF-kappaB-dependent pathway
- 1 January 2003
- journal article
- research article
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 293 (5) , 377-381
- https://doi.org/10.1078/1438-4221-00274
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Host-Pathogen Interactions: Subversion and Utilization of the NF-κB Pathway during InfectionInfection and Immunity, 2002
- CADD, a Chlamydia Protein That Interacts with Death ReceptorsJournal of Biological Chemistry, 2002
- Epithelial Cells Infected withChlamydophila pneumoniae(Chlamydia pneumoniae) Are Resistant to ApoptosisInfection and Immunity, 2001
- Characterization of Antiapoptotic Activities ofChlamydia pneumoniaein Human CellsInfection and Immunity, 2001
- Survival ofChlamydia pneumoniae-Infected Mono Mac 6 Cells Is Dependent on NF-κB Binding ActivityInfection and Immunity, 2001
- The modulation of host cell apoptosis by intracellular bacterial pathogensTrends in Microbiology, 2000
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced ApoptosisThe Journal of Experimental Medicine, 1998
- Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.Journal of Clinical Investigation, 1998
- The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteinsCell, 1995